glutathione s transferase deficiency The role of S-transferases in human disease pathogenesis and their current inhibitors Genetic Deficiency of Glutathione S-Transferase

In addition to an increase in prevalence, Rimland also noted a simultaneous increase in the relative ratio of regressive to infantile autism (Figure 2), as might be expected if a new and extremely potent trigger for the disease was introduced into the population which affected newborns and small children but not necessarily fetuses

T.ChakA.et al (2015a)

Mechanism of Action: As illustrated in Figure 2, pralidoxime can regenerate cholinesterase activity that has become inhibited by an organophosphate compound when given prior to when chemical aging between the organophosphate & cholinesterase enzyme has occurred

Simionescu BC, Drobota M, Timpu D, Vasiliu T, Constantinescu CA, Rebleanu D

(2010) The angiotensin IV analog Nle-Tyr-Leu-psi-(CH2-NH2)3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor/c-Met inhibitor